ClinConnect ClinConnect Logo
Search / Trial NCT07063368

Effects of Otago Exercises and Systematic Desensitization on Balance,Fall Risk and Basophobia Among Post Stroke Patients

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Stroke Fall Risk Otago Exercises Balance Systematic Desensitization Basophobia

ClinConnect Summary

This clinical trial is studying whether a special exercise program called Otago exercises, combined with a technique called systematic desensitization, can help improve balance, reduce the risk of falling, and lessen fear of falling in older adults who have had a stroke. The goal is to see if doing these exercises and relaxation methods together can make it easier and safer for stroke survivors to move around confidently.

The study is looking for men and women between 40 and 70 years old who have had a specific type of stroke (called sub-acute ischemic stroke) and can walk either on their own or with some help. Participants should be able to understand instructions well enough to follow the program, which is checked by a simple memory and thinking test. People who have serious joint problems, other neurological or mental health conditions, or severe vision or hearing issues won’t be able to join. If you take part, you will be guided through the exercises and relaxation techniques to see how they affect your balance and confidence over time. This study is still looking for participants who meet these criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria :
  • Both male and female patients
  • 40 to 70 Years of age
  • sub-acute ischemic stroke
  • Ability to walk with or without a caregiver
  • No cognitive dysfunction that would hinder understanding of the instructions
  • MoCA score between 18-24
  • Exclusion Criteria :
  • Patients previous participation in studies similar to the present study.
  • Participants who have other medical conditions such as severe arthritis or joint injuries.
  • Participants who have a history of significant neurological or psychiatric disorders
  • Participants who have severe visual or hearing impairments
  • Participants who are currently participating in another clinical trial or research study

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Sialkot, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Hira Jabeen, PhD

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported